Toggle navigation
Home
Search
Services
Blog
Contact
About
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David James
Virginia Commonwealth University, Richmond, VA, United States
Search 4 grants from David Mokler
Search grants from Virginia Commonwealth University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Preclinical development of myosolvins, a new class of medicine for asthma
MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm
Cellular and Molecular Studies of Bone Marrow Transplant
Food Safety and Security Monitoring Project (U18), FERN chemical Laboratories Coo
Core - Behavioral Pharmacology
Recently added grants:
Determining Optimal Treatment Intensity for Children with Language Impairment (LI)
Notch Signaling during Organ of Corti Maturation and Maintenance
Molecular and cellular mechanisms causing cleft lip/palate
Activin signaling in normal and disordered erythropoiesis
CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DA005260-02
Application #
3035089
Study Section
(DABA)
Project Start
1986-07-01
Project End
Budget Start
1986-07-01
Budget End
1986-12-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Related projects
NIH 1986
F32 DA
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David J. / Virginia Commonwealth University
NIH 1985
F32 DA
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David J. / Virginia Commonwealth University
Publications
Mokler, D J; Robinson, S E; Rosecrans, J A
(1987)
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
Eur J Pharmacol 138:265-8
Comments
Be the first to comment on David Mokler's grant